Morcellation Lawsuit | Morcellator Cancer, Leiomyosarcoma

Morcellation Lawsuit | Morcellator Cancer, Leiomyosarcoma

Morcellator Lawsuit, Morcellator Uterine Cancer, Morcellation cancer risk, Morcellation uterine cancer, fibroid Morcellation Cancer, Morcellation endometrial cancer, Leiomyosarcoma, morcellation wall street journal

morcellation-cancer-lawsuit-side-effect-cancer-leiomyosarcoma-Wright-SchulteWomen who were diagnosed with cancer following uterine surgery via the use of a power morcellator may be entitled to compensation from the manufacturer of the device. In April 2014, the U.S. Food & Drug Administration (FDA) advised doctors not to use power morcellators in minimally-invasive hysterectomies and fibroid procedures due to the risk that they could promote the spread of undetected cancerous uterine tissue. Even prior to the FDA warning, morcellation lawsuits due to uterine cancer were being filed in U.S. courts on behalf of women who were diagnosed with metastatic uterine cancer following a morcellator hysterectomy or fibroid removal.

Wright & Schulte LLC is currently investigating power morcellation lawsuits due to uterine cancer involving a number of device manufacturers, including Johnson & Johnson’s Ethicon, Inc. unit., Blue Endo, and LiNa Medical. If you or a woman you care about were diagnosed with uterine cancer, including uterine sarcoma or leiomyosarcoma, following power morcellation, our attorneys would like to hear from you. Our morcellation cancer lawyers may be able to help you obtain compensation for your injury-related damages, such as medical bills and lost wages, as well as payment for emotional distress, permanent disability, and pain and suffering. To learn more, please contact Wright & Schulte LLC as soon possible for a free, no obligation power morcellation lawsuit consultation to ensure you are treated fairly and receive all of the compensation the law allows.

Power Morcellation and Cancer

A power morcellator is a surgical tool that is used in minimally invasive procedures to grind uterine tissue and fibroids into fragments so that the material may be removed from the body via a small incision in the abdomen. Since the late 1990s, the use of power morcellators in hysterectomies and fibroid removals has become increasingly popular, with about 55,000-75,000 procedures performed in the U.S. every year. Today, power morcellators are marketed by a number of companies, including:

  • Blue Endo: MOREsolution Tissue Morcellator
  • FemRx: Diva Morcellator
  • Hologic: MyoSure
  • Interlace Medical: Hysteroscopic Morcellator
  • Johnson & Johnson/Ethicon: Gynecare X-Tract, Gynecare Morcellex Tissue Morcellator, and Morcellex Sigma
  • Karl Storz: Rotocut G1, G2, Steiner, and Sawalhell Supercut Morcellator
  • LiNA Medical: Xcise Cordless Laparoscopic Morcellator
  • Lumenis Inc.: VersaCut Morcellator
  • Nouvag: Morcellator TCM3000BL
  • Olympus: PlasmaSORD and Gyrus PKS PlasmaSORD
  • Richard Wolf: Morce-Power 2306 Electronic Morcellator
  • Smith & Nephew: Trueclear Hysteroscopic Morcellator

It is estimated that some .2% of women diagnosed with uterine fibroids actually have uterine sarcoma. Unfortunately, there is no way to easily test for this cancer. Now, a growing of body of evidence suggests that the use of power morcellation during uterine surgery can actually cause these undetected cancers to spread outside of the uterus, into a woman’s abdominal cavity. This action makes it far more likely that the cancer will spread throughout a patient’s body.

On April 17, 2014, the FDA announced that it would convene an advisory panel meeting to investigate the association between power morcellation and the spread of uterine cancer. The agency also discouraged the use of morcellation in hysterectomies and fibroid removal surgeries due to data that indicated the devices promote the spread of cancer outside of the uterus. The FDA’s announcement prompted Johnson & Johnson’s Ethicon unit to temporarily suspend sales of its power morcellators pending further guidance from the agency.

Morcellation Lawsuit Consultations

Wright & Schulte LLC is offering free legal consultations to victims of power morcellator cancer following uterine surgery. To learn if you may be eligible to file a morcellation lawsuit due to cancer, please contact Wright & Schulte LLC today by completing the online form on the right, or call toll free, 1-800-399-0795.

Morcellation Lawsuits & Information

Change.org – Petition by Hooman Noorchashm Boston, United States – Women’s Health Alert: Deadly Cancers of the Uterus Spread by Gynecologists. Stop Morcellating the Uterus in Minimally Invasive and Robot Assisted Hysterectomy and Myomectomy

Wall Street Journal – Doctor’s War on a Common Surgery

Wall Street Journal – How Morcellators Simplified the Hysterectomy but Posed a Hidden Cancer Risk

Wall Street Journal – FDA Advises Against Morcellator Use in Hysterectomies

Wall Street Journal – Philadelphia Hospital Restricts ‘Morcellation’ Procedure

Wall Street Journal – Doctors Eye Cancer Risk in Uterine Procedure

SarcomaHelp.org – Are Routine, Minimally Invasive Surgeries for Fibroids Safe?

Print